November 12, 2020 | 6:30 PM - 8:00 PM EST

Agenda Overview


TAVR vs. SAVR and VIV in Young Patients: Valve Survival, Patient Survival &  Eventual Need for Anticoagulation
Maurice Sarano, MD | Minneapolis, MN


SAVR, TAVR, ViV – Life in the Fast Lane: Who, What, When
Marc Gerdisch, MD | St. Francis Health


Blood Thinning in 2020 and Beyond:  Impact on AVR Patients and Artificial Prosthesis Selection
Mohanakrishnan Sathyamoorthy, MD |  TCU & UNTHSC School of Medicine


A Potential Game Changer in the Choice of AVR: PROACT Xa
Tracy Y. Wang, MD | Duke University